CervoMed Inc. (CRVO)

CervoMed Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	7.14	0	0	0	0
Gross Profit	7.14	0	0	0	0
Selling, General & Admin	6.52	2.14	7.45	6.44	4.83
Research & Development	8.44	1.34	8.5	9.43	6.62
Other Operating Expenses	0	0	8.73	0.1	0.1
Operating Expenses	14.96	3.48	24.68	15.97	11.55
Operating Income	-7.81	-3.48	-24.68	-15.97	-11.55
Interest Expense / Income	0	0	0	0	0
Other Expense / Income	-5.64	2.33	-0.14	-0.11	-0.09
Pretax Income	-2.17	-5.8	-24.54	-15.86	-11.47
Income Tax	0	0	-0.44	-1.68	0.33
Net Income	-2.17	-5.8	-24.1	-14.19	-11.8
Preferred Dividends	0	0	0	1.95	0
Net Income Common	-2.17	-5.8	-24.1	-16.14	-11.8
Shares Outstanding (Basic)	3	1	1	1	0
Shares Outstanding (Diluted)	3	1	1	1	0
Shares Change	413.65%	-60.08%	80.83%	702.68%	106.84%
EPS (Basic)	-0.82	-11.20	-18.57	-22.50	-132.00
EPS (Diluted)	-0.82	-11.20	-18.57	-22.50	-132.00
Free Cash Flow	-7.45	-2.57	-14.5	-13.55	-9.86
Free Cash Flow Per Share	-2.80	-4.96	-11.17	-18.88	-110.25
Gross Margin	100.00%	-	-	-	-
Operating Margin	-109.35%	-	-	-	-
Profit Margin	-30.40%	-	-	-	-
Free Cash Flow Margin	-104.27%	-	-	-	-
EBITDA	-2.17	-5.8	-24.45	-15.76	-11.37
EBITDA Margin	-30.40%	-	-	-	-
Depreciation & Amortization	0	0	0.09	0.1	0.1
EBIT	-2.17	-5.8	-24.54	-15.86	-11.47
EBIT Margin	-30.40%	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).